Capital One Ventures was among the exiting investors at data protection software provider Vera, which had raised $50m pre-acquisition.

The SFC-backed vaccine developer has wrapped up its series B-2 round after holding an initial close in early 2019.

The Novartis-backed retinal disease drug developer has secured $46.9m of series B capital from investors including Johnson & Johnson Innovation – JJDC.

You.i TV has been bought by investor WarnerMedia, which plans to implement its technology in its HBO Max on-demand service in Europe and Latin America.

Yardi's acquisition of mortgage brokerage software developer CommissionTrac has enabled seed investor Cox Enterprises to exit.

U-M's retinal disease drug developer has secured $46.9m of series B capital from investors including Mints.

Citi Ventures has exited transaction analysis platform developer Second Measure in a recently closed acquisition by Bloomberg.

The Novartis, Nan Fung, iCarbonX, Otsuka and Quest Diagnostics-backed proteomics technology developer has closed the second tranche of the round.

Cox Enterprises contributed to $100m in PIPE financing that will be raised by the lidar technology producer alongside the transaction.

The chemical analysis device developer has added $20m to an initial public offering following $70m in funding from investors including Saudi Aramco and Schlumberger.